Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

MicroRNAs and their delivery in diabetic fibrosis

Wonnacott, Alexa ORCID:, Denby, Laura, Coward, Richard J. M., Fraser, Donald J. and Bowen, Timothy ORCID: 2022. MicroRNAs and their delivery in diabetic fibrosis. Advanced Drug Delivery Reviews 182 , 114045. 10.1016/j.addr.2021.114045

[thumbnail of ADR_114045.pdf]
PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview


The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019 and is predicted to rise to 700 million by 2045. The associated financial and societal costs of this burgeoning epidemic demand an understanding of the pathology of this disease, and its complications, that will inform treatment to enable improved patient outcomes. Nearly two decades after the sequencing of the human genome, the significance of noncoding RNA expression is still being assessed. The family of functional noncoding RNAs known as microRNAs regulates the expression of most genes encoded by the human genome. Altered microRNA expression profiles have been observed both in diabetes and in diabetic complications. These transcripts therefore have significant potential and novelty as targets for therapy, therapeutic agents and biomarkers.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Elsevier
ISSN: 0169-409X
Date of First Compliant Deposit: 4 July 2022
Date of Acceptance: 4 November 2021
Last Modified: 06 Nov 2023 14:49

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics